Inhalable Antibodies for SARS-CoV-2

SARS-CoV-2 is transmitted through airborne droplets and tiny particles, making the respiratory system its primary route of infection. Researchers use this to their advantage by designing inhalable drugs comprised of tiny antibodies that protect against SARS-CoV-2. This webinar will explore the world of small, inhalable antibodies and how scientists use this new approach to guard against SARS-CoV-2 infection.

Topics to be covered

Aerosolized nanobodies for SARS-CoV-2 passive immunization
Multivalent nanobodies from llamas efficiently neutralize SARS-CoV-2

Speaker Information:

Aashish Manglik, MD, PhD

Assistant Professor

Department of Pharmaceutical Chemistry

University of California, San Francisco

Yi Shi, PhD

Assistant Professor

Department of Cell Biology

Program for Integrative Systems Biology

Carnegie Mellon University-Pitt Program in Computational Biology

University of Pittsburgh School of Medicine

Drug Discovery News or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.

Webinar Sponsors